IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL R FREDERICKS

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1699730341
CMS profile
212803
Location
DANVILLE, VA

General Payments · PY2018–2024

$5,956.30

  • Reported across 291 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,714.18

70 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology VA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,375.20 53
Consulting Fee $225.00 1
Education $113.98 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Ardelyx, Inc. $587.57 9
Retrophin, Inc. $448.78 23
Acerta Pharma LLC $139.48 7
Bayer HealthCare Pharmaceuticals Inc. $136.44 9
Otsuka America Pharmaceutical, Inc. $83.94 4
Mallinckrodt Hospital Products Inc. $56.05 3
Boehringer Ingelheim Pharmaceuticals, Inc. $53.98 3
Relypsa, Inc. $51.69 3
NOVARTIS PHARMACEUTICALS CORPORATION $39.70 2
ACCORD HEALTHCARE, INC. $35.27 2
OPKO Pharmaceuticals, LLC $35.03 2
AKEBIA THERAPEUTICS INC $16.96 1
Sumitomo Pharma America, Inc. $16.16 1
Fresenius USA Marketing, Inc. $13.13 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $329.20 20
PY2019 $614.78 20
PY2020 $201.47 12
PY2021 $1,142.01 52
PY2022 $1,027.49 59
PY2023 $927.17 58
PY2024 $1,714.18 70

Payment records · PY2024 (70)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ACCORD HEALTHCARE, INC. $16.17 05/07/2024 Food and Beverage Undisputed 01/23/2026 1120079154 CMS
ACCORD HEALTHCARE, INC. $19.10 07/09/2024 Food and Beverage Undisputed 01/23/2026 1120080500 CMS
AKEBIA THERAPEUTICS INC $16.96 04/22/2024 Food and Beverage Undisputed 01/23/2026 1145825307 CMS
Ardelyx, Inc. $16.24 01/11/2024 Food and Beverage Undisputed 01/23/2026 1146680850 CMS
Ardelyx, Inc. $0.91 02/19/2024 Food and Beverage Undisputed 01/23/2026 1146680852 CMS
Ardelyx, Inc. $15.31 02/19/2024 Food and Beverage Undisputed 01/23/2026 1146680854 CMS
Ardelyx, Inc. $14.80 03/20/2024 Food and Beverage Undisputed 01/23/2026 1146680856 CMS
Ardelyx, Inc. $16.46 06/06/2024 Food and Beverage Undisputed 01/23/2026 1146680858 CMS
Ardelyx, Inc. $2.30 06/06/2024 Food and Beverage Undisputed 01/23/2026 1146680860 CMS
Ardelyx, Inc. $485.66 07/09/2024 Food and Beverage Undisputed 01/23/2026 1146680862 CMS
Ardelyx, Inc. $25.13 11/06/2024 Food and Beverage Undisputed 01/23/2026 1146680864 CMS
Ardelyx, Inc. $10.76 12/06/2024 Food and Beverage Undisputed 01/23/2026 1146680866 CMS
AstraZeneca Pharmaceuticals LP $20.61 03/05/2024 Food and Beverage Undisputed 01/23/2026 1105354882 CMS
AstraZeneca Pharmaceuticals LP $23.15 04/01/2024 Food and Beverage Undisputed 01/23/2026 1105395948 CMS
AstraZeneca Pharmaceuticals LP $15.74 05/06/2024 Food and Beverage Undisputed 01/23/2026 1105529860 CMS
AstraZeneca Pharmaceuticals LP $15.26 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104429411 CMS
AstraZeneca Pharmaceuticals LP $15.42 10/14/2024 Food and Beverage Undisputed 01/23/2026 1105650752 CMS
AstraZeneca Pharmaceuticals LP $22.75 11/07/2024 Food and Beverage Undisputed 01/23/2026 1105555910 CMS
AstraZeneca Pharmaceuticals LP $26.55 12/04/2024 Food and Beverage Undisputed 01/23/2026 1105703722 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.21 01/22/2024 Food and Beverage Undisputed 01/23/2026 1086184700 CMS
Bayer Healthcare Pharmaceuticals Inc. $1.21 02/20/2024 Food and Beverage Undisputed 01/23/2026 1086088449 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.34 02/20/2024 Food and Beverage Undisputed 01/23/2026 1086222228 CMS
Bayer Healthcare Pharmaceuticals Inc. $11.74 03/21/2024 Food and Beverage Undisputed 01/23/2026 1086081748 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.94 04/19/2024 Food and Beverage Undisputed 01/23/2026 1086145169 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.01 06/10/2024 Food and Beverage Undisputed 01/23/2026 1086209783 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.35 07/18/2024 Food and Beverage Undisputed 01/23/2026 1086145627 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.24 11/12/2024 Food and Beverage Undisputed 01/23/2026 1086106904 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.40 12/11/2024 Food and Beverage Undisputed 01/23/2026 1086242926 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.14 03/19/2024 Food and Beverage Undisputed 01/23/2026 1118115673 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.88 08/01/2024 Food and Beverage Undisputed 01/23/2026 1118115675 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.96 12/03/2024 Food and Beverage Undisputed 01/23/2026 1118115677 CMS
Fresenius USA Marketing, Inc. $13.13 02/28/2024 Food and Beverage Undisputed 01/23/2026 1154203954 CMS
Mallinckrodt Hospital Products Inc. $20.11 06/25/2024 Food and Beverage Undisputed 01/23/2026 1145073056 CMS
Mallinckrodt Hospital Products Inc. $15.32 07/31/2024 Food and Beverage Undisputed 01/23/2026 1145073061 CMS
Mallinckrodt Hospital Products Inc. $20.62 08/13/2024 Food and Beverage Undisputed 01/23/2026 1145073065 CMS
Novartis Pharmaceuticals Corporation $25.57 02/22/2024 Food and Beverage Undisputed 01/23/2026 1086919887 CMS
Novartis Pharmaceuticals Corporation $14.13 10/03/2024 Food and Beverage Undisputed 01/23/2026 1086919899 CMS
OPKO Pharmaceuticals, LLC $16.75 02/06/2024 Education Undisputed 01/23/2026 1112844664 CMS
OPKO Pharmaceuticals, LLC $18.28 08/19/2024 Education Undisputed 01/23/2026 1112844666 CMS
Otsuka America Pharmaceutical, Inc. $15.39 04/11/2024 Food and Beverage Undisputed 01/23/2026 1118894070 CMS
Otsuka America Pharmaceutical, Inc. $23.90 07/22/2024 Food and Beverage Undisputed 01/23/2026 1118894072 CMS
Otsuka America Pharmaceutical, Inc. $23.74 10/07/2024 Food and Beverage Undisputed 01/23/2026 1118894074 CMS
Otsuka America Pharmaceutical, Inc. $20.91 11/11/2024 Food and Beverage Undisputed 01/23/2026 1118894076 CMS
Sumitomo Pharma America, Inc. $16.16 01/29/2024 Food and Beverage Undisputed 01/23/2026 1148852693 CMS
Travere Therapeutics, Inc. $16.41 01/25/2024 Food and Beverage Undisputed 01/23/2026 1149939634 CMS
Travere Therapeutics, Inc. $16.89 01/25/2024 Education Undisputed 01/23/2026 1149939638 CMS
Travere Therapeutics, Inc. $16.89 02/22/2024 Education Undisputed 01/23/2026 1149939643 CMS
Travere Therapeutics, Inc. $3.08 02/27/2024 Education Undisputed 01/23/2026 1149939614 CMS
Travere Therapeutics, Inc. $14.54 02/27/2024 Food and Beverage Undisputed 01/23/2026 1149939626 CMS
Travere Therapeutics, Inc. $16.89 02/27/2024 Education Undisputed 01/23/2026 1149939646 CMS
Travere Therapeutics, Inc. $3.08 03/12/2024 Education Undisputed 01/23/2026 1149939618 CMS
Travere Therapeutics, Inc. $3.08 04/23/2024 Education Undisputed 01/23/2026 1149939623 CMS
Travere Therapeutics, Inc. $19.46 04/23/2024 Food and Beverage Undisputed 01/23/2026 1149939662 CMS
Travere Therapeutics, Inc. $2.38 05/16/2024 Education Undisputed 01/23/2026 1149939583 CMS
Travere Therapeutics, Inc. $2.38 05/28/2024 Education Undisputed 01/23/2026 1149939587 CMS
Travere Therapeutics, Inc. $18.49 05/28/2024 Food and Beverage Undisputed 01/23/2026 1149939650 CMS
Travere Therapeutics, Inc. $2.38 06/18/2024 Education Undisputed 01/23/2026 1149939591 CMS
Travere Therapeutics, Inc. $18.58 06/18/2024 Food and Beverage Undisputed 01/23/2026 1149939654 CMS
Travere Therapeutics, Inc. $2.38 07/30/2024 Education Undisputed 01/23/2026 1149939595 CMS
Travere Therapeutics, Inc. $18.92 07/30/2024 Food and Beverage Undisputed 01/23/2026 1149939658 CMS
Travere Therapeutics, Inc. $2.38 08/07/2024 Education Undisputed 01/23/2026 1149939599 CMS
Travere Therapeutics, Inc. $2.38 08/07/2024 Education Undisputed 01/23/2026 1149939603 CMS
Travere Therapeutics, Inc. $2.38 08/07/2024 Education Undisputed 01/23/2026 1149939607 CMS
Travere Therapeutics, Inc. $2.38 09/16/2024 Education Undisputed 01/23/2026 1149939611 CMS
Travere Therapeutics, Inc. $225.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 1149939579 CMS
Travere Therapeutics, Inc. $16.00 10/28/2024 Food and Beverage Undisputed 01/23/2026 1149939630 CMS
Travere Therapeutics, Inc. $22.43 12/02/2024 Food and Beverage Undisputed 01/23/2026 1149939666 CMS
Vifor Pharma, Inc. $17.14 02/01/2024 Food and Beverage Undisputed 01/23/2026 1124035445 CMS
Vifor Pharma, Inc. $18.20 04/16/2024 Food and Beverage Undisputed 01/23/2026 1124037834 CMS
Vifor Pharma, Inc. $16.35 08/12/2024 Food and Beverage Undisputed 01/23/2026 1124051504 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.